{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T13:34:35Z","timestamp":1789220075059,"version":"build-2803163510"},"reference-count":175,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20252BAC240143"],"award-info":[{"award-number":["20252BAC240143"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangxi province Science and Technology Program of the Health Commission","award":["202311127"],"award-info":[{"award-number":["202311127"]}]},{"name":"Jiangxi Province Key Laboratory of bioengineering drugs","award":["2024SSY07061"],"award-info":[{"award-number":["2024SSY07061"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Cardiovascular diseases have high mortality rates and present a high burden on society and the global healthcare system. A large quantity of drugs have been developed, such as aspirin, ACE inhibitors, beta-blockers, and statins. Although these traditional drugs have decreased the morbidity and mortality of cardiovascular diseases, they still have multiple limitations. Due to their shortcomings, researchers have continued to search for novel targets for drug treatment. The tripartite motif (TRIM) protein family is a superfamily with E3 ubiquitin ligase activity and involves diversified processes including proliferation, development, signal transduction, and immune regulation. The latest research has shown that TRIM proteins participate in the progression of cardiovascular diseases, such as cardiac hypertrophy, cardiac ischemia\u2013reperfusion injury, heart failure, hypertension, atherosclerosis, and so on. In this review, we summarize the structure and function of TRIM proteins, as well as the mechanisms of their involvement in various cardiovascular diseases, aiming to raise awareness of the importance of TRIM proteins in cardiovascular disease research and treatment. Advancing our understanding of mechanisms mediated by TRIM proteins may emphasize their contributions to cardiovascular diseases and provide the opportunity to develop novel and targeted therapeutic strategies to combat cardiovascular diseases.<\/jats:p>","DOI":"10.3390\/biom16050676","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:06:21Z","timestamp":1777860381000},"page":"676","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Emerging Role and Potential Therapeutic Application of TRIM Proteins in Cardiovascular Diseases"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3764-7750","authenticated-orcid":false,"given":"Yiyang","family":"Cui","sequence":"first","affiliation":[{"name":"The Queen Mary School, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1679-0581","authenticated-orcid":false,"given":"Yuxuan","family":"Wen","sequence":"additional","affiliation":[{"name":"The Queen Mary School, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinling","family":"Wang","sequence":"additional","affiliation":[{"name":"Jiangxi Province Key Laboratory of Bioengineering Drugs, The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixiu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Jiangxi Province Key Laboratory of Bioengineering Drugs, The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100633","DOI":"10.1016\/j.ajpc.2024.100633","article-title":"Global burden of cardiovascular diseases attributed to low physical activity: An analysis of 204 countries and territories between 1990 and 2019","volume":"17","author":"Luo","year":"2024","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/1995-705X.185130","article-title":"Framingham contribution to cardiovascular disease","volume":"17","author":"Hajar","year":"2016","journal-title":"Heart Views"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.semvascsurg.2022.02.007","article-title":"An assessment of the current medical management of thoracic aortic disease: A patient-centered scoping literature review","volume":"35","author":"Pena","year":"2022","journal-title":"Semin. Vasc. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/CRD.0000000000000185","article-title":"Medical Management of Rheumatic Heart Disease: A Systematic Review of the Evidence","volume":"26","author":"Russell","year":"2018","journal-title":"Cardiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.3892\/ol.2020.11817","article-title":"Effects of aspirin on the gastrointestinal tract: Pros vs. cons (Review)","volume":"20","author":"Li","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.phrs.2017.07.026","article-title":"Antihypertensive drugs","volume":"124","author":"Laurent","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_7","first-page":"e121","article-title":"Response by Ward et al to Letter Regarding Article, \u201cStatin Toxicity: Mechanistic Insights and Clinical Implications\u201d","volume":"124","author":"Ward","year":"2019","journal-title":"Circ. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Camacho-Encina, M., Booth, L.K., Redgrave, R.E., Folaranmi, O., Spyridopoulos, I., and Richardson, G.D. (2024). Cellular Senescence, Mitochondrial Dysfunction, and Their Link to Cardiovascular Disease. Cells, 13.","DOI":"10.20944\/preprints202401.0975.v1"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e12563","DOI":"10.1111\/cpr.12563","article-title":"Role of pyroptosis in cardiovascular disease","volume":"52","author":"Zeng","year":"2019","journal-title":"Cell Prolif."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Abdul Ghani, M.A., Ugusman, A., Latip, J., and Zainalabidin, S. (2023). Role of Terpenophenolics in Modulating Inflammation and Apoptosis in Cardiovascular Diseases: A Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065339"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1093\/eurheartj\/ehaf374","article-title":"Ferroptosis in cardiovascular disease: Regulatory mechanisms and therapeutic implications","volume":"46","author":"Zhao","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1002\/mco2.413","article-title":"Epicardial adipose tissue, metabolic disorders, and cardiovascular diseases: Recent advances classified by research methodologies","volume":"4","author":"Song","year":"2023","journal-title":"MedComm"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41420-023-01560-5","article-title":"Research progress on post-translational modification of proteins and cardiovascular diseases","volume":"9","author":"Cheng","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12272-025-01542-4","article-title":"Mechanistic insights and emerging therapeutic strategies targeting endothelial dysfunction in cardiovascular diseases","volume":"48","author":"Heo","year":"2025","journal-title":"Arch. Pharm. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jare.2023.01.011","article-title":"Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape","volume":"54","author":"Gu","year":"2023","journal-title":"J. Adv. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41375-018-0222-x","article-title":"TRIM44 promotes quiescent multiple myeloma cell occupancy and survival in the osteoblastic niche via HIF-1\u03b1 stabilization","volume":"33","author":"Chen","year":"2018","journal-title":"Leukemia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tibs.2017.01.002","article-title":"TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis","volume":"42","author":"Hatakeyama","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"116846","DOI":"10.1016\/j.biopha.2024.116846","article-title":"E3 ubiquitin ligase TRIM31: A potential therapeutic target","volume":"176","author":"Deng","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)00077-5","article-title":"RING finger proteins: Mediators of ubiquitin ligase activity","volume":"102","author":"Joazeiro","year":"2000","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2413","article-title":"TRIM family proteins and their emerging roles in innate immunity","volume":"8","author":"Ozato","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/BST20160325","article-title":"Structural determinants of TRIM protein function","volume":"45","author":"Esposito","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/cr.2014.46","article-title":"Structural insights into the TRIM family of ubiquitin E3 ligases","volume":"24","author":"Li","year":"2014","journal-title":"Cell Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1093\/emboj\/20.9.2140","article-title":"The tripartite motif family identifies cell compartments","volume":"20","author":"Reymond","year":"2001","journal-title":"EMBO J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1073\/pnas.92.7.2563","article-title":"A family of proteins structurally and functionally related to the E6-AP ubiquitin\u2013protein ligase","volume":"92","author":"Huibregtse","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1073\/pnas.0509996103","article-title":"Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5 alpha restriction factor","volume":"103","author":"Stremlau","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.immuni.2012.11.013","article-title":"The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors","volume":"38","author":"Versteeg","year":"2013","journal-title":"Immunity"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Short, K.M., Hopwood, B., Yi, Z., and Cox, T.C. (2002). MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: Implications for the clinical variability of X-linked opitz GBBB syndrome and other developmental disorders. BMC Cell Biol., 3.","DOI":"10.1186\/1471-2121-3-1"},{"key":"ref_28","first-page":"1","article-title":"Phylogeny of the TRAF\/MATH domain","volume":"Volume 597","author":"Wu","year":"2007","journal-title":"TNF Receptor Associated Factors (TRAFs)"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ni.2492","article-title":"The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA","volume":"14","author":"Zhang","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"111886","DOI":"10.1016\/j.cellsig.2025.111886","article-title":"A brief overview of the E3 ubiquitin ligase: TRIM7","volume":"134","author":"Fan","year":"2025","journal-title":"Cell. Signal."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Bell, J.L., Malyukova, A., Holien, J.K., Koach, J., Parker, M.W., Kavallaris, M., Marshall, G.M., and Cheung, B.B. (2012). TRIM16 Acts as an E3 Ubiquitin Ligase and Can Heterodimerize with Other TRIM Family Members. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037470"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1016\/j.cub.2018.11.026","article-title":"TRIM proteins","volume":"29","author":"Vunjak","year":"2019","journal-title":"Curr. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1006\/jmbi.1999.3429","article-title":"RING Domains: Master Builders of Molecular Scaffolds?","volume":"295","author":"Borden","year":"2000","journal-title":"J. Mol. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Li, Y., Li, S., and Wu, H. (2022). Ubiquitination-Proteasome System (UPS) and Autophagy Two Main Protein Degradation Machineries in Response to Cell Stress. Cells, 11.","DOI":"10.3390\/cells11050851"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14206","article-title":"The E3 ubiquitin ligase CHIP in normal cell function and in disease conditions","volume":"1460","author":"Wang","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zhang, X., Huo, C., Liu, Y., Su, R., Zhao, Y., and Li, Y. (2022). Mechanism and Disease Association with a Ubiquitin Conjugating E2 Enzyme: UBE2L3. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.793610"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The Ubiquitin Code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"189576","DOI":"10.1016\/j.bbcan.2026.189576","article-title":"Dual role of TRIM E3-ligases in hepatocellular carcinoma: Mechanistic insights and therapeutic perspectives","volume":"1881","author":"Cao","year":"2026","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1089\/ars.2019.7826","article-title":"Polyubiquitin Chains Linked by Lysine Residue 48 (K48) Selectively Target Oxidized Proteins In Vivo","volume":"31","author":"Manohar","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/10409238.2017.1325829","article-title":"Ubiquitin enzymes in the regulation of immune responses","volume":"52","author":"Ebner","year":"2017","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ni.3641","article-title":"The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination","volume":"18","author":"Liu","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41418-023-01239-5","article-title":"TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11\/xCT K11-linked ubiquitination and degradation","volume":"31","author":"Wang","year":"2024","journal-title":"Cell Death Differ."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e109777","DOI":"10.15252\/embj.2021109777","article-title":"TRIM27 cooperates with STK38L to inhibit ULK1-mediated autophagy and promote tumorigenesis","volume":"41","author":"Yang","year":"2022","journal-title":"EMBO J."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhang, S., Wang, Z., Cheng, R., Yang, X., Jiang, A., Zhu, L., and Qin, X. (2026). TRIM21 promotes astrocyte-mediated neuroinflammation in experimental a utoimmune encephalomyelitis by stabilizing RGMa via K33-linked ubiquit ination. J. Neuroinflamm., in press.","DOI":"10.1186\/s12974-026-03769-4"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2010.03.029","article-title":"Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity","volume":"141","author":"Zeng","year":"2010","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.molcel.2010.08.029","article-title":"MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases","volume":"39","author":"Doyle","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nrc3139","article-title":"TRIM proteins and cancer","volume":"11","author":"Hatakeyama","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac Hypertrophy: The Good, the Bad, and the Ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"H8","DOI":"10.1152\/ajpheart.01303.2004","article-title":"Does load-induced ventricular hypertrophy progress to systolic heart failure?","volume":"289","author":"Berenji","year":"2005","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/cvr\/cvu013","article-title":"Pregnancy as a cardiac stress model","volume":"101","author":"Chung","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14728222.2022.2031974","article-title":"Emerging therapeutic targets for cardiac hypertrophy","volume":"26","author":"Winkle","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3892\/mmr.2023.13060","article-title":"Tripartite motif-containing 14 may aggravate cardiac hypertrophy via the AKT signalling pathway in neonatal rat cardiomyocytes and transgenic mice","volume":"28","author":"Hou","year":"2023","journal-title":"Mol. Med. Rep."},{"key":"ref_53","first-page":"8323","article-title":"Tripartite motif 27 promotes cardiac hypertrophy via PTEN\/Akt\/mTOR signal pathways","volume":"13","author":"Chen","year":"2022","journal-title":"Bioengineered"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1111\/jcmm.15257","article-title":"Tripartite motif 10 regulates cardiac hypertrophy by targeting the PTEN\/AKT pathway","volume":"24","author":"Yang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.116.07741","article-title":"Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor \u03b2\u2013Activated Kinase 1\u2013Dependent Signaling Pathways","volume":"69","author":"Chen","year":"2017","journal-title":"Hypertension"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41401-020-0496-1","article-title":"Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes","volume":"42","author":"Liu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"115253","DOI":"10.1016\/j.biopha.2023.115253","article-title":"Paeoniflorin alleviates AngII-induced cardiac hypertrophy in H9c2 cells by regulating oxidative stress and Nrf2 signaling pathway","volume":"165","author":"Ren","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.molcel.2016.02.007","article-title":"TRIM21 Ubiquitylates SQSTM1\/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis","volume":"61","author":"Pan","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.7150\/thno.99340","article-title":"Cardiomyocyte-derived USP28 negatively regulates antioxidant response and promotes cardiac hypertrophy via deubiquitinating TRIM21","volume":"14","author":"Han","year":"2024","journal-title":"Theranostics"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12964-025-02323-8","article-title":"TRIM24 regulates chromatin remodeling and calcium dynamics in cardiomyocytes","volume":"23","author":"Neu","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00109-023-02318-3","article-title":"TRIM-containing 44 aggravates cardiac hypertrophy via TLR4\/NOX4-induced ferroptosis","volume":"101","author":"Wu","year":"2023","journal-title":"J. Mol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.1074\/jbc.M116.752543","article-title":"TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels","volume":"292","author":"Borlepawar","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1042\/CS20150619","article-title":"Tripartite motif 32 prevents pathological cardiac hypertrophy","volume":"130","author":"Chen","year":"2016","journal-title":"Clin. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1093\/hmg\/ddp167","article-title":"TRIM32 is an E3 ubiquitin ligase for dysbindin","volume":"18","author":"Locke","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1161\/CIRCRESAHA.121.318866","article-title":"The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy","volume":"130","author":"Liu","year":"2022","journal-title":"Circ. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"175735","DOI":"10.1016\/j.ejphar.2023.175735","article-title":"Trim65 attenuates isoproterenol-induced cardiac hypertrophy by promoting autophagy and ameliorating mitochondrial dysfunction via the Jak1\/Stat1 signaling pathway","volume":"949","author":"Liu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3892\/ijmm.2025.5539","article-title":"Trim38 attenuates pressure overload-induced cardiac hypertrophy by suppressing the TAK1\/JNK\/P38 signaling pathway","volume":"55","author":"Pang","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1083\/jcb.200402033","article-title":"Muscle ring finger protein-1 inhibits PKCepsilon activation and prevents cardiomyocyte hypertrophy","volume":"167","author":"Arya","year":"2004","journal-title":"J. Cell Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCHEARTFAILURE.113.000713","article-title":"Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A","volume":"7","author":"Maejima","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1159\/000489241","article-title":"Current Mechanistic Concepts in Ischemia and Reperfusion Injury","volume":"46","author":"Wu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"110714","DOI":"10.1016\/j.intimp.2023.110714","article-title":"The role of PI3K\/AKT signaling pathway in myocardial ischemia-reperfusion injury","volume":"123","author":"Deng","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: A neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/cbin.11716","article-title":"Downregulation of tripartite motif protein 11 attenuates cardiomyocyte apoptosis after ischemia\/reperfusion injury via DUSP1-JNK1\/2","volume":"46","author":"He","year":"2022","journal-title":"Cell Biol. Int."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"8939","DOI":"10.18632\/aging.103106","article-title":"miR-378a-3p inhibits ischemia\/reperfusion-induced apoptosis in H9C2 cardiomyocytes by targeting TRIM55 via the DUSP1-JNK1\/2 signaling pathway","volume":"12","author":"Tan","year":"2020","journal-title":"Aging"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"963689720949247","DOI":"10.1177\/0963689720949247","article-title":"Knockdown of Tripartite Motif 8 Protects H9C2 Cells Against Hypoxia\/Reoxygenation-Induced Injury Through the Activation of PI3K\/Akt Signaling Pathway","volume":"29","author":"Dang","year":"2020","journal-title":"Cell Transplant."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1080\/13880209.2022.2096644","article-title":"Salvianolic acid B inhibits myocardial I\/R-induced ROS generation and cell apoptosis by regulating the TRIM8\/GPX1 pathway","volume":"60","author":"Lu","year":"2022","journal-title":"Pharm. Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.18632\/aging.101995","article-title":"E3-ubiquitin ligase TRIM6 aggravates myocardial ischemia\/reperfusion injury via promoting STAT1-dependent cardiomyocyte apoptosis","volume":"11","author":"Zeng","year":"2019","journal-title":"Aging"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"117110","DOI":"10.1016\/j.bcp.2025.117110","article-title":"LRRC8A\/TRIM21 axis exacerbates myocardial ischemia\/reperfusion injury by blocking FAK\/NF-kappaB pathway","volume":"241","author":"Hou","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3892\/mmr.2020.11810","article-title":"Zenglv Fumai Granule protects cardiomyocytes against hypoxia\/reoxygenation-induced apoptosis via inhibiting TRIM28 expression","volume":"23","author":"Zhang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbrc.2021.03.061","article-title":"TRIM27 protects against cardiac ischemia-reperfusion injury by suppression of apoptosis and inflammation via negatively regulating p53","volume":"557","author":"Li","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e13815","DOI":"10.7717\/peerj.13815","article-title":"TRIM38 protects H9c2 cells from hypoxia\/reoxygenation injury via the TRAF6\/TAK1\/NF-\u03baB signalling pathway","volume":"10","author":"Lu","year":"2022","journal-title":"PeerJ"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbrc.2022.09.057","article-title":"TRIM16 exerts protective function on myocardial ischemia\/reperfusion injury through reducing pyroptosis and inflammation via NLRP3 signaling","volume":"632","author":"Shi","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1161\/CIRCULATIONAHA.110.954628","article-title":"MG53 Constitutes a Primary Determinant of Cardiac Ischemic Preconditioning","volume":"121","author":"Cao","year":"2010","journal-title":"Circulation"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/cvr\/cvr029","article-title":"MG53 participates in ischaemic postconditioning through the RISK signalling pathway","volume":"91","author":"Zhang","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/CIRCULATIONAHA.119.044998","article-title":"Cardiac Ischemic Preconditioning Promotes MG53 Secretion Through H2O2-Activated Protein Kinase C-\u03b4 Signaling","volume":"142","author":"Shan","year":"2020","journal-title":"Circulation"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Wang, Q., Park, K.H., Geng, B., Chen, P., Yang, C., Jiang, Q., Yi, F., Tan, T., Zhou, X., and Bian, Z. (2022). MG53 Inhibits Necroptosis Through Ubiquitination-Dependent RIPK1 Degradation for Cardiac Protection Following Ischemia\/Reperfusion Injury. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.868632"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yjmcc.2014.01.010","article-title":"S-nitrosylation of TRIM72 at cysteine 144 is critical for protection against oxidation-induced protein degradation and cell death","volume":"69","author":"Kohr","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yjmcc.2019.09.008","article-title":"A knock-in mutation at cysteine 144 of TRIM72 is cardioprotective and reduces myocardial TRIM72 release","volume":"136","author":"Fillmore","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.yexcr.2017.12.007","article-title":"Potential role of MG53 in the regulation of transforming-growth-factor-\u03b21-induced atrial fibrosis and vulnerability to atrial fibrillation","volume":"362","author":"Guo","year":"2018","journal-title":"Exp. Cell Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial Fibrillation","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.mayocp.2016.08.022","article-title":"The State of the Art","volume":"91","author":"Morin","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7861\/clinmed.2023-23.5.Cardio2","article-title":"Atrial fibrillation: A contemporary update","volume":"23","author":"Saleh","year":"2023","journal-title":"Clin. Med."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Sagris, M., Vardas, E.P., Theofilis, P., Antonopoulos, A.S., Oikonomou, E., and Tousoulis, D. (2021). Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010006"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"10543","DOI":"10.1111\/jcmm.16985","article-title":"MicroRNA-146b-5p promotes atrial fibrosis in atrial fibrillation by repressing TIMP4","volume":"25","author":"Ye","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2567.2006.02336.x","article-title":"Fibrosis in heart disease: Understanding the role of transforming growth factor-\u03b21 in cardiomyopathy, valvular disease and arrhythmia","volume":"118","author":"Khan","year":"2006","journal-title":"Immunology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1080\/15384101.2020.1827183","article-title":"MG53\/CAV1 regulates transforming growth factor-\u03b21 signaling-induced atrial fibrosis in atrial fibrillation","volume":"19","author":"Zhang","year":"2020","journal-title":"Cell Cycle"},{"key":"ref_97","first-page":"1148","article-title":"Pulmonary hypertension: A contemporary review","volume":"205","author":"Frost","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_99","first-page":"72","article-title":"The right ventricle in pulmonary arterial hypertension: Lessons from the left heart","volume":"19","author":"Konstam","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1159\/000506150","article-title":"Emerging Role of TRIM Family Proteins in Cardiovascular Disease","volume":"145","author":"Zhang","year":"2020","journal-title":"Cardiology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/0115701611241848231114111618","article-title":"The Role of TRIM Proteins in Vascular Disease","volume":"22","author":"Chen","year":"2024","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1186\/s12967-023-04712-4","article-title":"A role of TRIM59 in pulmonary hypertension: Modulating the protein ubiquitylation modification","volume":"21","author":"Liu","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.7150\/thno.40889","article-title":"A combat with the YAP\/TAZ-TEAD oncoproteins for cancer therapy","volume":"10","author":"Pobbati","year":"2020","journal-title":"Theranostics"},{"key":"ref_104","first-page":"9358","article-title":"TRIM24 promotes PASMC proliferation via AKT\/mTORC1 pathway in pulmonary arterial hypertension","volume":"13","author":"Xu","year":"2022","journal-title":"Bioengineered"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jmcb\/mjz040","article-title":"TRIM14 promotes endothelial activation via activating NF-\u03baB signaling pathway","volume":"12","author":"Huang","year":"2020","journal-title":"J. Mol. Cell Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10863-021-09880-w","article-title":"TRIM32 inhibits the proliferation and migration of pulmonary artery smooth muscle cells through the inactivation of PI3K\/Akt pathway in pulmonary arterial hypertension","volume":"53","author":"Hu","year":"2021","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_107","first-page":"774","article-title":"Research progress on hypoxia-induced phenotypic transformation of pulmonary artery smooth muscle cells","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Physiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41418-021-00874-0","article-title":"The E3 ubiquitin ligase TRIM31 plays a critical role in hypertensive nephropathy by promoting proteasomal degradation of MAP3K7 in the TGF-\u03b21 signaling pathway","volume":"29","author":"Zhang","year":"2022","journal-title":"Cell Death Differ."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(14)61889-4","article-title":"The war against heart failure: The Lancet lecture","volume":"385","author":"Braunwald","year":"2015","journal-title":"Lancet"},{"key":"ref_110","first-page":"e895","article-title":"AHA\/ACC\/HFSA Guideline for the management of heart failure","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1378\/chest.06-2674","article-title":"Medical therapy for pulmonary arterial hypertension: Updated ACCP evidence-based clinical practice guidelines","volume":"131","author":"Badesch","year":"2007","journal-title":"Chest"},{"key":"ref_113","first-page":"88","article-title":"Right ventricular failure: Molecular and cellular mechanisms","volume":"118","author":"Bruggen","year":"2016","journal-title":"Circ. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1161\/01.RES.0000259559.48597.32","article-title":"Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo","volume":"100","author":"Willis","year":"2007","journal-title":"Circ. Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKK\u03b2\/NF-\u03baB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1006\/jmbi.2001.4448","article-title":"Identification of muscle-specific ring finger proteins as potential regulators of the titin kinase domain","volume":"306","author":"Centner","year":"2001","journal-title":"J. Mol. Biol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Li, H., Chen, C., and Wang, D.W. (2021). Inflammatory cytokines, immune cells, and organ interactions in heart failure. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.695047"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e27955","DOI":"10.7554\/eLife.27955","article-title":"The calcineurin\u2013FoxO\u2013MuRF1 signaling pathway regulates myofibril integrity in cardiomyocytes","volume":"6","author":"Shimizu","year":"2017","journal-title":"eLife"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"18135","DOI":"10.1073\/pnas.0404341102","article-title":"Muscle-specific RING finger 1 is a bona fide ligase that degrades cardiac troponin I","volume":"101","author":"Kedar","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.3390\/ijms15069302","article-title":"Rare Variants in Genes Encoding MuRF1 and MuRF2 Are Modifiers of Hypertrophic Cardiomyopathy","volume":"15","author":"Su","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Chunthorng-Orn, J., Noureddine, M., Dawson, P.W.J., Lord, S.O., Ng, J., Boyton, L., Gehmlich, K., Mohammed, F., and Lai, Y.-C. (2025). HCM-Associated MuRF1 Variants Compromise Ubiquitylation and Are Predicted to Alter Protein Structure. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26083921"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ydbio.2010.12.024","article-title":"Developmental regulation of MURF ubiquitin ligases during myofibril assembly and turnover","volume":"351","author":"Perera","year":"2011","journal-title":"Dev. Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tcb.2005.11.007","article-title":"From A to Z and back? Multicompartment proteins in the sarcomere","volume":"16","author":"Lange","year":"2006","journal-title":"Trends Cell Biol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1126\/science.1110463","article-title":"The Kinase Domain of Titin Controls Muscle Gene Expression and Protein Turnover","volume":"308","author":"Lange","year":"2005","journal-title":"Science"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.yjmcc.2019.12.008","article-title":"Genetic and functional implications of an exonic TRIM55 variant in heart failure","volume":"138","author":"Heliste","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_127","first-page":"1104","article-title":"TRIM55 Aggravates Cardiomyocyte Apoptosis After Myocardial Infarction via Modulation of the Nrf2\/HO-1 Pathway","volume":"9","author":"Bu","year":"2024","journal-title":"Basic Transl. Sci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1073\/pnas.0611726104","article-title":"Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction","volume":"104","author":"Fielitz","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_132","first-page":"1","article-title":"SCAP Interacts with Trim27 to Promote Vascular Neointimal Hyperplasia by Regulating the Stability and Ubiquitination of I\u03baB\u03b1","volume":"17","author":"Yao","year":"2025","journal-title":"Aging Dis."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/cvr\/cvaf084","article-title":"Novel roles of Nrf3\u2013Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia","volume":"121","author":"Chen","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"117430","DOI":"10.1016\/j.atherosclerosis.2023.117430","article-title":"TRIM65 promotes vascular smooth muscle cell phenotypic transformation by activating PI3K\/Akt\/mTOR signaling during atherogenesis","volume":"390","author":"Zhou","year":"2024","journal-title":"Atherosclerosis"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e70168","DOI":"10.1002\/ctm2.70168","article-title":"Disturbed shear stress promotes atherosclerosis through TRIM21-regulated MAPK6 degradation and consequent endothelial inflammation","volume":"15","author":"Wang","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.2174\/0929867331666230822152350","article-title":"TRIM65 Suppresses oxLDL-induced Endothelial Inflammation byInteraction with VCAM-1 in Atherogenesis","volume":"31","author":"Ma","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"42","DOI":"10.21037\/atm-22-6044","article-title":"TRIM59 attenuates ox-LDL-induced endothelial cell inflammation, apoptosis, and monocyte adhesion through AnxA2","volume":"11","author":"Zeng","year":"2023","journal-title":"Ann. Transl. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/CAD.0000000000000466","article-title":"Nitroxoline shows antimyeloma activity by targeting the TRIM25\/p53 axle","volume":"28","author":"Mao","year":"2017","journal-title":"Anti-Cancer Drugs"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13046-020-01617-8","article-title":"JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25\/SP1\/MMP2 axis","volume":"39","author":"Chen","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3892\/etm.2021.10665","article-title":"Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway","volume":"22","author":"Du","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/cvr\/cvn137","article-title":"MicroRNAs: Novel regulators in cardiac development and disease","volume":"79","author":"Thum","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40259-022-00549-3","article-title":"Therapeutic siRNA: State-of-the-Art and Future Perspectives","volume":"36","author":"Friedrich","year":"2022","journal-title":"BioDrugs"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e70892","DOI":"10.1111\/jcmm.70892","article-title":"Circular RNA Rftn1 Promotes Cardiac Hypertrophy In Vitro and In Vivo by Sponging miRNA-1192 to Upregulate Tripartite Motif Protein 25 and 41","volume":"29","author":"Liu","year":"2025","journal-title":"J. Cell. Mol. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s13346-021-00995-6","article-title":"Extension in the approaches to treat cancer through siRNA system: A beacon of hope in cancer therapy","volume":"12","author":"Rautela","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1093\/eurheartj\/ehac463","article-title":"Small non-coding RNA therapeutics for cardiovascular disease","volume":"43","author":"Shah","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/mt.2011.22","article-title":"Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer","volume":"19","author":"Pulicherla","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature18002","article-title":"Proteome-wide covalent ligand discovery in native biological systems","volume":"534","author":"Backus","year":"2016","journal-title":"Nature"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1039\/D3CS01127E","article-title":"Innovative, combinatorial and high-throughput approaches to degrader synthesis","volume":"53","author":"Stevens","year":"2024","journal-title":"Chem. Soc. Rev."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbpa.2019.02.022","article-title":"Targeted protein degradation: Elements of PROTAC design","volume":"50","author":"Paiva","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.chembiol.2020.07.020","article-title":"PROTACs: An Emerging Therapeutic Modality in Precision Medicine","volume":"27","author":"Nalawansha","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1080\/14756366.2022.2076675","article-title":"Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: Advances and future challenges","volume":"37","author":"Wang","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1038\/s41401-023-01088-5","article-title":"Bioinspired PROTAC-induced macrophage fate determination alleviates atherosclerosis","volume":"44","author":"Huang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e70401","DOI":"10.1002\/mco2.70401","article-title":"Proteolysis-Targeting Chimera (PROTAC): Current Applications and Future Directions","volume":"6","author":"Fan","year":"2025","journal-title":"MedComm"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1002\/cbic.202000787","article-title":"Targeting TRIM Proteins: A Quest towards Drugging an Emerging Protein Class","volume":"22","author":"Mukhopadhyay","year":"2021","journal-title":"Chembiochem"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1021\/jm501092z","article-title":"Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment","volume":"58","author":"Zhao","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.csbj.2019.01.009","article-title":"Targeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer Treatment","volume":"17","author":"Cossu","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.compbiolchem.2017.08.014","article-title":"Inhibition of TRAF6-Ubc13 interaction in NFkB inflammatory pathway by analyzing the hotspot amino acid residues and protein-protein interactions using molecular docking simulations","volume":"70","author":"Biswas","year":"2017","journal-title":"Comput. Biol. Chem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1087057111423417","article-title":"TR-FRET-based high-throughput screening assay for identification of UBC13 inhibitors","volume":"17","author":"Madiraju","year":"2012","journal-title":"J. Biomol. Screen."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.drudis.2021.04.029","article-title":"Small molecules targeting ubiquitination to control inflammatory diseases","volume":"26","author":"Li","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/s41467-018-04214-8","article-title":"Molecular mechanism of influenza A NS1-mediated TRIM25 recognition and inhibition","volume":"9","author":"Koliopoulos","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.15252\/embj.201593741","article-title":"Functional role of TRIM E3 ligase oligomerization and regulation of catalytic activity","volume":"35","author":"Koliopoulos","year":"2016","journal-title":"EMBO J."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"108367","DOI":"10.1016\/j.jbc.2025.108367","article-title":"The structural basis of TRIM25-mediated regulation of RIG-I","volume":"301","author":"Li","year":"2025","journal-title":"J. Biol. Chem."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.chembiol.2014.09.001","article-title":"Small-molecule inhibitors of protein-protein interactions: Progressing toward the reality","volume":"21","author":"Arkin","year":"2014","journal-title":"Chem. Biol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cbpa.2011.05.024","article-title":"Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I)","volume":"15","author":"Morelli","year":"2011","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Fei, X., Song, C., Cui, J., Li, Y., Lei, X., and Tang, H. (2025). The role of deubiquitinases in cardiovascular diseases: Mechanisms and therapeutic implications. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1582049"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.bbrc.2016.08.100","article-title":"Ubiquitin-specific protease 14 regulates cardiac hypertrophy progression by increasing GSK-3beta phosphorylation","volume":"478","author":"Liu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.yjmcc.2015.04.012","article-title":"Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2","volume":"84","author":"Wang","year":"2015","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCRESAHA.112.270207","article-title":"Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy","volume":"111","author":"Chen","year":"2012","journal-title":"Circ. Res."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/heartjnl-2020-316913","article-title":"Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy","volume":"106","author":"Ochoa","year":"2020","journal-title":"Heart"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s11886-024-02096-5","article-title":"Precision Genetic Therapies: Balancing Risk and Benefit in Patients with Heart Failure","volume":"26","author":"Johnston","year":"2024","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Hughes, M.F., Lenighan, Y.M., Godson, C., and Roche, H.M. (2018). Exploring Coronary Artery Disease GWAs Targets with Functional Links to Immunometabolism. Front. Cardiovasc. Med., 5.","DOI":"10.3389\/fcvm.2018.00148"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2017.10.020","article-title":"Conserved structural and functional aspects of the tripartite motif gene family point towards therapeutic applications in multiple diseases","volume":"185","author":"Gushchina","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Zhang, W., Zheng, L., and Guo, Q. (2022). The roles and targeting options of TRIM family proteins in tumor. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.999380"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Shihata, W.A., Putra, M.R.A., and Chin-Dusting, J.P.F. (2017). Is There a Potential Therapeutic Role for Caveolin-1 in Fibrosis?. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00567"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Fan, J., Zheng, S., Wang, M., and Yuan, X. (2024). The critical roles of caveolin-1 in lung diseases. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1417834"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/5\/676\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:32:51Z","timestamp":1777861971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/5\/676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":175,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["biom16050676"],"URL":"https:\/\/doi.org\/10.3390\/biom16050676","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]}}}